Genetic interaction between Lyn, Ets1, and Btk in the control of antibody levels

Journal of Immunology

Volumn 195, Issue 5, 2015, Pages 1955-1963

  Mayeux, Jessica ^a   Skaug, Brian ^a   Luo, Wei ^b   Russell, Lisa M ^b   John, Shinu ^b   Saelee, Prontip ^b   Abbasi, Hansaa ^a   Li, Quan Zhen ^c   Garrett Sinha, Lee Ann ^b   Satterthwaite, Anne B ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BRUTON TYROSINE KINASE; CD69 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN KINASE LYN; TRANSCRIPTION FACTOR ETS 1; AGAMMAGLOBULINAEMIA TYROSINE KINASE; ANTIBODY; ETS1 PROTEIN, MOUSE; IMMUNOGLOBULIN M; LYN PROTEIN-TYROSINE KINASE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; GENE INTERACTION; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ANIMAL; B LYMPHOCYTE; BLOOD; C57BL MOUSE; CELL DIFFERENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTASIS; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; SPLENOMEGALY; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; AUTOANTIBODIES; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPISTASIS, GENETIC; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOGLOBULIN M; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMA CELLS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEIN C-ETS-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; SPLENOMEGALY; SRC-FAMILY KINASES;

EID: 84940118449     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500165     Document Type: Article

References (56)

1. John, S., L. Russell, S. S. Chin, W. Luo, R. Oshima, and L. A. Garrett-Sinha. 2014. Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation. Mol. Cell. Biol. 34: 522-532.
2. John, S. A., J. L. Clements, L. M. Russell, and L. A. Garrett-Sinha. 2008. Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor Blimp-1. J. Biol. Chem. 283: 951-962.
3. Garrett-Sinha, L. A. 2013. Review of Ets1 structure, function, and roles in immunity. Cell. Mol. Life Sci. 70: 3375-3390.
4. Wang, D., S. A. John, J. L. Clements, D. H. Percy, K. P. Barton, and L. A. Garrett-Sinha. 2005. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int. Immunol. 17: 1179-1191.
5. Luo, W., J. Mayeux, T. Gutierrez, L. Russell, A. Getahun, J. Müller, T. Tedder, J. Parnes, R. Rickert, L. Nitschke, et al. 2014. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. J. Immunol. 193: 909-920.
6. Barton, K., N. Muthusamy, C. Fischer, C. N. Ting, T. L. Walunas, L. L. Lanier, and J. M. Leiden. 1998. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9: 555-563.
7. Mouly, E., K. Chemin, H. V. Nguyen, M. Chopin, L. Mesnard, M. Leite-de- Moraes, O. Burlen-defranoux, A. Bandeira, and J. C. Bories. 2010. The Ets-1 transcription factor controls the development and function of natural regulatory T cells. J. Exp. Med. 207: 2113-2125.
8. Dang, J., S. Shan, J. Li, H. Zhao, Q. Xin, Y. Liu, X. Bian, and Q. Liu. 2014. Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus. Tissue Antigens 83: 401-408.
9. Guo, X. F., S. Shan, J. Dang, R. F. Qiu, H. L. Zhao, Q. Xin, Y. C. Liu, J. X. Li, and Q. J. Liu. 2013. [Association of two SNPs in 3′ UTR of ETS1 gene with systemic lupus erythematosus in a northern Chinese Han population.] Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 30: 477-480.
10. Leng, R. X., W. Wang, H. Cen, M. Zhou, C. C. Feng, Y. Zhu, X. K. Yang, M. Yang, Y. Zhai, B. Z. Li, et al. 2012. Gene-gene and gene-sex epistatic interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in systemic lupus erythematosus. PLoS One 7: e51090.
11. Zhong, H., X. L. Li, M. Li, L. X. Hao, R. W. Chen, K. Xiang, X. B. Qi, R. Z. Ma, and B. Su. 2011. Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res. Ther. 13: R186.
12. Li, Y., L. D. Sun, W. S. Lu, W. L. Hu, J. P. Gao, Y. L. Cheng, Z. Y. Yu, S. Yao, C. F. He, J. L. Liu, et al. 2010. Expression analysis of ETS1 gene in peripheral blood mononuclear cells with systemic lupus erythematosus by real-time reverse transcription PCR. Chin. Med. J. (Engl.) 123: 2287-2288.
13. He, C. F., Y. S. Liu, Y. L. Cheng, J. P. Gao, T. M. Pan, J. W. Han, C. Quan, L. D. Sun, H. F. Zheng, X. B. Zuo, et al. 2010. TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 19: 1181-1186.
14. Yang,W., N. Shen, D. Q. Ye, Q. Liu, Y. Zhang, X. X. Qian, N. Hirankarn, D. Ying, H. F. Pan, C. C. Mok, et al; Asian Lupus Genetics Consortium. 2010. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 6: e1000841.
15. Wang, C., A. Ahlford, T. M. Järvinen, G. Nordmark, M. L. Eloranta, I. Gunnarsson, E. Svenungsson, L. Padyukov, G. Sturfelt, A. Jönsen, et al. 2013. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur. J. Hum. Genet. 21: 994-999.
16. Han, J. W., H. F. Zheng, Y. Cui, L. D. Sun, D. Q. Ye, Z. Hu, J. H. Xu, Z. M. Cai, W. Huang, G. P. Zhao, et al. 2009. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41: 1234-1237.
17. Wen, Z., L. Xu, X. Chen, W. Xu, Z. Yin, X. Gao, and S. Xiong. 2013. Auto-antibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway. J. Immunol. 190: 5411-5422.
18. Xiang, N., X. P. Li, X. M. Li, G. S. Wang, J. H. Tao, H. F. Pan, X. Fang, Q. Ma, and N. Yu. 2014. Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T regulatory cells from patients with systemic lupus erythematosus. Clin. Exp. Med. 14: 375-381.
19. Xu, Y., K. W. Harder, N. D. Huntington, M. L. Hibbs, and D. M. Tarlinton. 2005. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22: 9-18.
20. Chan, V. W., F. Meng, P. Soriano, A. L. DeFranco, and C. A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7: 69-81.
21. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311.
22. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T.Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549-560.
23. Gutierrez, T., K. E. Halcomb, A. J. Coughran, Q. Z. Li, and A. B. Satterthwaite. 2010. Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Eur. J. Immunol. 40: 1897-1905.
24. Khan, W. N. 2001. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase. Immunol. Res. 23: 147-156.
25. Satterthwaite, A. B., Z. Li, and O. N. Witte. 1998. Btk function in B cell development and response. Semin. Immunol. 10: 309-316.
26. Bolland, S., R. N. Pearse, T. Kurosaki, and J. V. Ravetch. 1998. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8: 509-516.
27. Maeda, A., A. M. Scharenberg, S. Tsukada, J. B. Bolen, J. P. Kinet, and T. Kurosaki. 1999. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. Oncogene 18: 2291-2297.
28. Flores-Borja, F., P. S. Kabouridis, E. C. Jury, D. A. Isenberg, and R. A. Mageed. 2005. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 52: 3955-3965.
29. Liossis, S. N., E. E. Solomou, M. A. Dimopoulos, P. Panayiotidis, M. M. Mavrikakis, and P. P. Sfikakis. 2001. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J. Investig. Med. 49: 157-165.
30. Lu, R., G. S. Vidal, J. A. Kelly, A. M. Delgado-Vega, X. K. Howard, S. R. Macwana, N. Dominguez, W. Klein, C. Burrell, I. T. Harley, et al; BIOLUPUS and GENLES Multicenter Collaborations. 2009. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun. 10: 397-403.
31. Harley, J. B., M. E. Alarcón-Riquelme, L. A. Criswell, C. O. Jacob, R. P. Kimberly, K. L. Moser, B. P. Tsao, T. J. Vyse, C. D. Langefeld, S. K. Nath, et al; International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN). 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40: 204-210.
32. Manjarrez-Orduño, N., E. Marasco, S. A. Chung, M. S. Katz, J. F. Kiridly, K. R. Simpfendorfer, J. Freudenberg, D. H. Ballard, E. Nashi, T. J. Hopkins, et al. 2012. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat. Genet. 44: 1227-1230.
33. Tsantikos, E., M. J. Maxwell, N. Kountouri, K. W. Harder, D. M. Tarlinton, and M. L. Hibbs. 2012. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development. J. Immunol. 189: 1726-1736.
34. Satterthwaite, A. B., C. A. Lowell, W. N. Khan, P. Sideras, F. W. Alt, and O. N. Witte. 1998. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways. J. Exp. Med. 188: 833-844.
35. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, et al. 1992. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 360: 225-231.
36. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Müller, A. B. Kantor, L. A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3: 283-299.
37. Muthusamy, N., K. Barton, and J. M. Leiden. 1995. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377: 639-642.
38. Eyquem, S., K. Chemin, M. Fasseu, M. Chopin, F. Sigaux, A. Cumano, and J. C. Bories. 2004. The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factor. Eur. J. Immunol. 34: 3187-3196.
39. Li, Q. Z., J. Zhou, A. E. Wandstrat, F. Carr-Johnson, V. Branch, D. R. Karp, C. Mohan, E. K. Wakeland, and N. J. Olsen. 2007. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin. Exp. Immunol. 147: 60-70.
40. Oracki, S. A., E. Tsantikos, C. Quilici, A. Light, T. Schmidt, A. M. Lew, J. E. Martin, K. G. Smith, M. L. Hibbs, and D. M. Tarlinton. 2010. CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice. J. Immunol. 184: 757-763.
41. Hua, Z., A. J. Gross, C. Lamagna, N. Ramos-Hernández, P. Scapini, M. Ji, H. Shao, C. A. Lowell, B. Hou, and A. L. DeFranco. 2014. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center antinuclear antibody production in Lyn-deficient mice. J. Immunol. 192: 875-885.
42. Moisan, J., R. Grenningloh, E. Bettelli, M. Oukka, and I. C. Ho. 2007. Ets-1 is a negative regulator of Th17 differentiation. J. Exp. Med. 204: 2825-2835.
43. Scapini, P., Y. Hu, C. L. Chu, T. S. Migone, A. L. Defranco, M. A. Cassatella, and C. A. Lowell. 2010. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J. Exp. Med. 207: 1757-1773.
44. Clements, J. L., S. A. John, and L. A. Garrett-Sinha. 2006. Impaired generation of CD8+ thymocytes in Ets-1-deficient mice. J. Immunol. 177: 905-912.
45. Tsantikos, E., S. A. Oracki, C. Quilici, G. P. Anderson, D. M. Tarlinton, and M. L. Hibbs. 2010. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J. Immunol. 184: 1348-1360.
46. Lamagna, C., Y. Hu, A. L. DeFranco, and C. A. Lowell. 2014. B cell-specific loss of Lyn kinase leads to autoimmunity. J. Immunol. 192: 919-928.
47. Rubtsov, A. V., K. Rubtsova, J. W. Kappler, and P. Marrack. 2013. TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice. Immunol. Res. 55: 210-216.
48. Rubtsov, A. V., K. Rubtsova, A. Fischer, R. T. Meehan, J. Z. Gillis, J. W. Kappler, and P. Marrack. 2011. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood 118: 1305-1315.
49. Hao, Y., P. O'Neill, M. S. Naradikian, J. L. Scholz, and M. P. Cancro. 2011. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118: 1294-1304.
50. Whyburn, L. R., K. E. Halcomb, C. M. Contreras, C. A. Lowell, O. N. Witte, and A. B. Satterthwaite. 2003. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice. J. Immunol. 171: 1850-1858.
51. Kersseboom, R., L. Kil, R. Flierman, M. van der Zee, G. M. Dingjan, S. Middendorp, A. Maas, and R. W. Hendriks. 2010. Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells. Eur. J. Immunol. 40: 2643-2654.
52. Groom, J. R., C. A. Fletcher, S. N. Walters, S. T. Grey, S. V. Watt, M. J. Sweet, M. J. Smyth, C. R. Mackay, and F. Mackay. 2007. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J. Exp. ed. 204: 1959-1971.
53. Kim, H. A., G. Y. Seo, and P. H. Kim. 2011. Macrophage-derived BAFF induces AID expression through the p38MAPK/CREB and JNK/AP-1 pathways. J. Leukoc. Biol. 89: 393-398.
54. Gutierrez, T., J. M. Mayeux, S. B. Ortega, N. J. Karandikar, Q. Z. Li, D. Rakheja, X. J. Zhou, and A. B. Satterthwaite. 2013. IL-21 promotes the production of anti- DNA IgG but is dispensable for kidney damage in lyn-/- mice. Eur. J. Immunol. 43: 382-393.
55. Vinuesa, C. G., Y. Sunners, J. Pongracz, J. Ball, K. M. Toellner, D. Taylor, I. C. MacLennan, and M. C. Cook. 2001. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation. Eur. J. Immunol. 31: 1340-1350.
56. Guinamard, R., M. Okigaki, J. Schlessinger, and J. V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1: 31-36.